Lead Healthcare Affairs & Patient Engagement - Mumbai

The Position

Leading the MA HCA TA strategy for OPU in line with global strategy. Customise MA, HCA strategy to meet the needs of local payers in OPU for Therapeutic Areas and adapt to local market dynamics to maximize growth and accelerate access. Building MA HCA TA plans including understanding of the healthcare gaps for the required therapy area, burden of disease study and value proposition & enlisting plans according to IMETA strategic priorities. Monitor, interpret and shape developments and gaps in healthcare trends and policies for our pipeline HP product portfolio and supporting the public market and the brand team for the existing commercialized portfolio. Lead the TA HCA input into the therapy area forecasting exercise. Map and lead the interactions with the key stakeholders identified in shaping the landscape in the therapy area. Implement the market access plan aligned for the respective therapy area.

Tasks & Responsibilities

• Building Market Access, HCA TA strategy in OPU; including Pricing, Reimbursement and Enlisting strategies for the TA, in alignment with IMETA MA strategy and OPU strategic priorities. Leading TA MA plan for OPU; review & monitor TA MA plans for the OPU to achieve Market access priorities. Ensure Cross-functional collaboration and alignment. Be the main point of contact for Market Access topics in assigned TA with IMETA and OPU brand teams. Establish close working relationships with colleagues in OPU (Marketing, Medical, Commercial Operations). Co-Facilitate and contribute to the ICPs & MMM. Guide and review the MA plans developed by the OPU including resources allocation (budget and FTE) and content. Support OPU with Market access TA-related payers requests.

• Preparing for the future by developing healthcare affairs and market access strategies by pro-actively identifying opportunities and market shaping initiatives (payers survey, ad boards, Market research, etc.). Ensure launch readiness by designing critical market access activities, like preparing payers, budget owners, etc. to enhance patient access. Provide adequate support for OPUs to ensure successful launch of new products / indications.

• Mitigating the impact of LOE. Proactively develop and implement strategies to address the challenges posed by generic competition. Develop healthcare affairs communication plans for payers to address concerns and ensure a smooth transition during the LOE events. Develop plans with multiple market access scenarios for generic entry and pricing impact. Develop second brand strategies when appropriate. Maximize our product life cycle by enforcing our patent portfolio and regulatory exclusivity where legally appropriate.